Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-04-23

Design Therapeutics (DSGN)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$3,544,300
Pratik Shah total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
0%
Say-on-pay support, latest vote
Companies that benchmark against DSGN
No companies currently name DSGN as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Pratik Shah$395,000$144,000$0$2,754,300$237,000$0$14,000$3,544,300
President, Chief Executive Officer and Chairperson
Chris Storgard339,310144,72601,396,960135,724014,0002,030,270
Chief Medical Officer
Sean Jeffries484,0006,40001,193,530193,600014,0001,891,530
Chief Operating Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Pratik Shah$3,544,300
Chris Storgard2,030,270
Sean Jeffries1,891,530

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Pratik ShahOption218,7502.48
Pratik ShahOption600,0006.17
Pratik ShahOption437,5002.48
Pratik ShahOption145,2507.97
Pratik ShahOption23,75012.77
Sean JeffriesOption260,0006.17
Sean JeffriesOption215,8342.54
Sean JeffriesOption49,0007.97
Sean JeffriesOption17,50012.77
Chris StorgardOption400,0004.71
05

Incentive-plan design — the Compensation Discussion & Analysis

CEO STI target (% of salary)
CEO LTI target (% of salary)
Independent consultant
Clawback policytrue
Anti-hedging
Anti-pledging
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
202692,01162,441,42962,441,4290%Failed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20260%a

a. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Rodney Lappe, Ph.DIndependent · Research and Development (Chair) · Nominating and Corporate Governance (Chair)$65,000$174,035$239,035
Rodney LappeIndependent65,000239,035
Justin GoverIndependent · Audit · Compensation (Chair) · Newly elected3,109220,670223,779
Simeon George, M.DIndependent · Compensation81,95854,714136,672
John SchmidIndependent · Audit (Chair) · Compensation66,00054,714120,714
Heather Berger, Ph.DIndependent · Audit · Research and Development55,00054,714109,714
Heather BergerIndependent55,00054,714109,714
Deepa PrasadIndependent · Nominating and Corporate Governance51,40154,714106,115
Arsani William, M.DIndependent · Departed during FY41,23054,71495,944
Pratik Shah, Ph.DEmployee director · Board Chair0
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)12,500 / 12,000 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$483,698
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$483,698

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

Year Ended December 31,
10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Design Therapeutics2025Pratik Shah$395,000$0$2,754,300$237,000$3,544,300

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Pratik ShahDEF 14A2026-04-230001193125-26-173678Section “Executive Compensation”. As printed: 3,544,300. Filing ↗machine: r2 · c23 · span 420474–420483
2Section 01, Chris StorgardDEF 14A2026-04-230001193125-26-173678Section “Executive Compensation”. As printed: 2,030,270. Filing ↗machine: r6 · c23 · span 454519–454528
3Section 01, Sean JeffriesDEF 14A2026-04-230001193125-26-173678Section “Executive Compensation”. As printed: 1,891,530. Filing ↗machine: r4 · c23 · span 437504–437513
4Section 08, Rodney Lappe, Ph.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 239,035. Filing ↗
5Section 08, Rodney LappeDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 239,035. Filing ↗
6Section 08, Justin GoverDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 223,779. Filing ↗
7Section 08, Simeon George, M.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 136,672. Filing ↗
8Section 08, John SchmidDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 120,714. Filing ↗
9Section 08, Heather Berger, Ph.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 109,714. Filing ↗
10Section 08, Heather BergerDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 109,714. Filing ↗
11Section 08, Deepa PrasadDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 106,115. Filing ↗
12Section 08, Arsani William, M.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 95,944. Filing ↗
13Section 08, Pratik Shah, Ph.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 0. Filing ↗
14Section 06, 2026 voteForm 8-K2026-04-230001193125-26-173678Item 5.07 · say-on-pay result. As reported: 0%. Filing ↗
15Section 09b board cost (computed)ComputedcomputedCash 483,698 + equity 0 + all other 0 = 483,698, summed across the director compensation table rows.machine: formula: Σ = 483,698
16Design Therapeutics (subject), Section 10b CEO totalDEF 14A2026-04-230001193125-26-173678CEO total compensation as printed in Design Therapeutics's own proxy. As printed: 3,544,300. Filing ↗machine: r2 · c23 · span 420474–420483